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Background: Ameloblastoma is a neoplasm classified as a benign epithelial odontogenic tumor of the jaws, grow 
slowly and are locally invasive. The aim of the present study was to investigate the incidence, treatment, and com-
plication of patients with ameloblastoma in East-Indonesia during six years retrospective study.
Material and Methods: This retrospective study included 84 patients who were diagnosed with ameloblastoma 
from 2011 to 2016. There were 56 patients with treatment data available. Data from each patient, including gender, 
age, histologic type, the size of the tumor, radiologic form, tumor location, type of treatment, and complication 
were reviewed and analyzed retrospectively.
Results: Fourteen patients were diagnosed with unicystic ameloblastoma (25%), thirty two patients with mul-
ticystic follicular ameloblastoma (57%) and ten patients with an unspecified multicystic ameloblastoma (18%). 
A total of about 35 patients were treated conservatively (62.5%) and 21 patients were treated radically (37.5%). 
Swelling was present as a pre-operative complication in all 56 cases (100%). There were no complaints concern-
ing speech.
Conclusions: The majority findings of the histologic type were multicystic ameloblastoma and their location were 
in the mandible. Most ameloblastoma were treated conservatively and reconstructions were made with only tita-
nium plates and not bone graft. 
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Introduction
Ameloblastoma is a neoplasm classified as a benign epi-
thelial odontogenic tumor of the jaws. Ameloblastomas 
grow slowly and are locally invasive. A vast majority of 
ameloblastomas are unilateral (95%) and occur in the 
posterior region of the jaws (85%). Most tumors are lo-
cated in the mandible (80-93%) (1,2).
A systemic review by MacDonald-Jankowski et al. (3) 
showed that number of ameloblastomas per hospital 
was significantly higher in Asian or African popula-
tions than European or American hospitals. Lu et al. (4) 
studied the Chinese populations and showed a mean age 
of 31.4 years with a 1.5:1 male : female ratio and 90.8% 
of the tumors were in mandible. A study by Hatada et 
al. (5) on the Japanese population showed a mean age 
of 34.7 years with a 1.6:1 male : female ratio and 92.6% 
was located in the mandible. There was no study found 
in Indonesian population.
The main goals of ameloblastoma treatment are complete 
removal of the tumor and restoration of function and 
aesthetics (6). Broadly speaking, this can be achieved 
in two ways with surgical management; through con-
servative approach or radical approach (6-8). The con-
servative approach of treating ameloblastoma includes 
enucleation and curettage, whereas the radical approach 
includes resection or excision of a lesion that includes a 
measurable perimeter of investing bone (7).
The incidence of ameloblastoma, treatment, and compli-
cation has not been studied in the Indonesian population 
especially in East-Indonesia. The purpose of this study 
was to conduct a retrospective investigation to examine 
these important topics in East-Indonesia.
 
Material and Methods
The data was collected for three months in Sulawesi, 
Indonesia during the period of April 13th-July 8th, 
2016. The data was obtained from two hospitals, these 
were Hasanuddin University Dental Hospital in Makas-
sar and Undata General Hospital in Palu. Patients’ files 
were collected for the period of January 2011-June 2016, 
where 84 patients were diagnosed with ameloblastoma.
The inclusion criteria of treatment data were diagnosed 
with ameloblastoma and treated for the same. The ex-
clusion criteria were incomplete patients’ files (no treat-
ment mentioned) and histopathological diagnoses other 
than ameloblastoma.
This study used a questionnaire to gather the data. Un-
known data was left blank. Histologic type was con-
firmed by Pathology Anatomi (PA) result, if it was 
available in the medical files. The radiologic form was 
scored by one oral surgeon if radiographs were avail-
able.
Hong et al. made eight groups: anterior mandible (cus-
pid to cuspid); left and right posterior mandibles (pre-
molar to molar); both rami (third molar to condyle); 
anterior maxilla (cuspid to cuspid); and both posterior 
maxilla (premolar to pterygoid plates) (9). In this study, 
the groups was used and altered four location: posterior 
maxilla; anterior maxilla; posterior mandible; anterior 
mandible. The cuspids in the maxilla and the mandible 
indicate the anterior border and posterior border. No 
difference was made between left and right.
Data from each patient, including gender, age, histologic 
type, location, the size of tumor, radiologic form, treat-
ment of ameloblastoma, reconstruction, pre-operative, 
and post-operative complications were collected from 
medical reports and reviewed and analyzed retrospec-
tively.
A database was created using Microsoft Excel and col-
lected data was analyzed using SPSS v23 for statisti-
cal significance. Tests used were chi-square and an 




Eighty-four patients were diagnosed with ameloblasto-
ma between January 2011 and June 2016. Forty-nine pa-
tients were treated in Makassar and 35 in Palu. Eighty-
four patients were used in epidemiological data in this 
study including 40 males (48%) and 44 females (52%). 
The treatment data was not available for all patients, 
files of 28 patients turned out to be unusable for this 
study, forty-five cases were obtained from Makassar 
and 11 from Palu totaling to 56 usable patient files for 
treatment, which included data of 21 males (37.5%) and 
35 females (62.5%).
- Epidemiological Data
The mean age was 39.7 years (SD 17.4), with a mini-
mum of five years and a maximum of 85 years. Out of 
84 patients, 56 patients had a PA result included in the 
medical files. Fourteen patients were diagnosed with 
unicystic ameloblastoma (25%), thirty two patients 
with multicystic follicular ameloblastoma (57%) and 
ten patients with an unspecified multicystic ameloblas-
toma (18%). The location of tumor according to the four 
regions showed six cases in the maxilla, five (10.4%) 
in posterior and one (2.1%) in anterior, the mandible 
showed 38 (81.3%) cases in posterior and three (6.3%) 
cases in anterior. Radiographs were available for 56 
patients. Nineteen radiolucencies (34%) were scored as 
uniloculated and 37 radiolucencies (66%) as multilocu-
lated (Table 1).
- Treatment Data
Most patients were treated in 2014 but it is not known 
why there was such a spike in treatments in that year. 
The location of the tumor was known for 39 cases, three 
patients had a tumor in the maxilla. Of the 36 tumors 
in the mandible, ten tumors had no specified location, 
three were specified to be in the anterior region, and 23 
were in the posterior region (Table 2).
Med Oral Patol Oral Cir Bucal. 2018 Jan 1;23 (1):e54-8.                                                                                                              The epidemiology, treatment, and complication of ameloblastoma
e56
A total of about 35 patients were treated conservatively 
(62.5%) and 21 patients were treated radically (37.5%). 
Most patients treated conservatively underwent enucle-
ation and curettage (62.8%), the rest received only enu-
cleation (37.25). Of the patients treated radically, about 
10 patients received a marginal resection (47.6%) and 10 
patients received segmental resection (47.6%), while only 
one patient underwent a maxillectomy (4.8%) (Table 2).
A total of about five patients were documented to have 
received a reconstruction after tumor removal (8.9%). 
One of those reconstructions was an unspecified autog-
enous bone graft, the remaining four were reconstruc-
tion made with titanium plates. The patient with the 
bone graft had undergone a conservative treatment of 
enucleation and curettage. Three titanium plate recon-
structions were performed after an enucleation.
The follow-up was documented for 56 patients (25%) 
for a periods of up to four years. Six recurrences were 
noted for these 56 patients (42.8%). Both of the patients 
who had undergone enucleation experienced a recur-
rence. Forty percent of the patients that had enucleation 
and curettage had a recurrence. One patient treated with 
segmental resection had a recurrence after four years 
(Table 3).
- Complication
Swelling was present as a pre-operative complication 
in all 56 cases (100%). Out of 56 patients, the pain was 
present in eight cases (10%), numbness or an altered 
feeling was present in two cases (2%), breathing ob-
struction was present in one case (1%), and swallowing 
problems were present in two cases (2%). There were no 




    Male
    Female
Patients treated in each year
    2011
    2012
    2013
    2014
    2015
    2016
Tumor location 
    Maxilla
    Mandible
         Anterior
         Posterior
         Unspecified
    Unknown
Type of treatments
    Conservative
        Enucleation + curettage
        Enucleation
    Radical
        Marginal resection
        Segmental resection





































Table 2: Gender distribution, number of patients treated in each year, location, and 
type of treatment.
n (%)
Histologic Type (n =56)
   Unicystic
   Follicular Multicystic
   Unspecified Multicystic
Tumor Location (n = 48)
   Maxilla (n = 6)
      Posterior
      Anterior
   Mandible (n = 42)
      Posterior
      Anterior
Radiolucencies (n = 56)
   Unilocuated



















Table 1: Disease-related results of patients with ameloblastoma.
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Discussion
Patient files in Dental Hospital, especially in Makassar 
were barely maintained and documented a decade ago, 
but for the past five years, documentation has improved. 
This is a promising prospect for future (prospective re-
search) in East-Indonesia. Setting up prospective studies 
for the treatment of ameloblastoma would most definite-
ly help the continuing development and improvement of 
local health care. 
Patients often wait for seeking medical care until their 
life is significantly impacted by the tumor (2). Since 
ameloblastoma is a slow growing tumor, it can take 
many years until a patient seeks medical care, at which 
point the treatment is much more complicated due to 
the size of the tumor. The patients in Indonesia showed 
a mean age of 39.7 years, which is similar to the main 
age of Caucasians (39.9 years) and Asian (41.2 years) 
according to Reichart et al. (10). In this study, the mean 
age was 41.00 for males and 38.64 for females. In the 
studies of Chukweneke et al. and Oomens et al. a higher 
age for males was also found (11,12).
Histologic distribution within this study was 25% uni-
cystic ameloblastoma, about 57% multicystic amelo-
blastoma and an unspecified multicystic ameloblastoma 
18%. These findings are similar to the findings from 
Gandhi et al. (13), which found 23% unicystic amelo-
blastoma and 77% multicystic ameloblastoma and find-
ings from Saghravanian et al. (14), which found 24% 
with unicystic ameloblastoma, about 73% with multi-
cystic ameloblastoma and 3% with extraosseous amelo-
blastoma.
Radiographically, the currents study had less unilocu-
lated and more multiloculated radiolucencies compared 
to the finding of Gandhi et al. and Bansal et al. (13,15). 
It seems that the children have a higher percentage of 
uniloculated radiolucencies and a lower percentage of 
multiloculated radiolucencies, which is in accordance 
with a higher percentage of unicystic ameloblastoma 
and a lower percentage of multicystic ameloblastoma. 
But it should be stressed that both unicystic and mul-
ticystic ameloblastoma could show both uniloculated 
and multiloculated radiolucencies. In other words, the 
radiographic appearance is not dependent on the histo-
logical type (15-17).
The mean age of unicystic ameloblastoma (49.75 years) 
in the current study was higher than multicystic amelo-
blastoma (38.18 years). This difference was not signifi-
cant. However, in literature, a lower age was found for 
unicystic ameloblastoma than multicystic ameloblastoma 
(1,14). Also, a higher percentage of unicystic ameloblas-
toma and a lower percentage of multicystic ameloblas-
toma were found within studies including only children, 
compared to studies including all ages (10,16,17).
Reconstructions were mostly done with titanium metal 
plates, which is notable in the modern literature that 
mainly discusses and offers studies about bone graft. 
Recent literature on titanium plates is mostly limited 
to case report (18,19). Older study show high rates of 
complications (20-22), which seems to be confirmed by 
this study where two out of four patients experienced 
post-operative complications; one patient had exces-
sive wound bleeding and one patient experienced plate 
rejection after difficult closure during the surgery. The 
ameloblastoma reconstructions are less invasive and 
less expensive for the patient since no bone has to be 
grafted, which could explain why it is used so often 
East-Indonesia.











Table 4: Pre-operative complications of patients 
with ameloblastoma. Some patients had more 
than one complication
Recurrence No recurrence
Numbers of follow-ups and recurrences after set amount of 
years
    1 year
    2 years
    3 years
    4 years
The known recurrence for all patients that had follow-ups, 
specified for each type of treatment
    Enucleation
    Enucleation + Curettage












           0
6
1
Table 3: Follow-up and recurrences of patients with ameloblastoma.
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In East-Indonesia, most patients were treated conserva-
tively (62.5%) despite a majority of patients being diag-
nosed with multicystic ameloblastoma. There is no ex-
planation for this, but it could be that treatment is decided 
by the size of the tumor and not by the histological type. 
Patients may also deny radical treatment due to financial 
factors or reluctance towards the risk of deformities, lip 
numbness, malocclusion, or poor mastication (23).
The swelling was found in 70% cases in the study of 
MacDonald-Janskowski et al. (3). In this study, the 
swelling is the chief complaint. These swellings were 
larger in size compared with literature and the patients 
waited longer before seeking medical assistance.
A cultural reason would be that Indonesian people have 
a higher threshold of seeking medical assistance. The 
geographical restriction could also apply. On the Su-
lawesi Island, there are only a few big cities with hospi-
tals and oral surgeons. The infrastructure and distances 
from their homes to these big cities could be a restrict-
ing factor to seek medical assistance.
The present study has several shortcomings. This study 
was limited to East-Indonesia (Makassar and Palu). 
Further study related to ameloblastoma is still required 
in other health centers in Indonesia. However, the num-
ber of treated patients is not equally distributed among 
the hospitals. Most patients are treated at the Dental 
Hospital Hasanuddin University Makassar and General 
Hospital Palu. Therefore, our results may not be gener-
alizable to the whole population of Indonesia. Because 
this study was retrospective, the analysis may include 
an information bias. However, the results presented in 
this study are similar to the reports from other studies. 
Furthermore, the analysis in this report provides impor-
tant data for improving the treatment plans for amelo-
blastoma surgery.
In the Indonesian retrospective study regarding amelo-
blastoma, the majority findings of the histologic type 
were multicystic ameloblastoma and their location was 
in the mandible. Most ameloblastomas were treated con-
servatively in East-Indonesia and reconstructions were 
mostly made with only titanium plates and not by bone 
graft, which is an older technique not used much in the 
Western world anymore. These reconstructions some-
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